Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

521. The use of aromatherapy to treat behavioural problems in dementia Full Text available with Trip Pro

The use of aromatherapy to treat behavioural problems in dementia The use of aromatherapy to treat behavioural problems in dementia The use of aromatherapy to treat behavioural problems in dementia Nguyen Q, Paton C CRD summary The authors concluded that the few studies that evaluated the effects of aromatherapy on behavioural and psychological symptoms in patients with dementia reported mixed results. The authors’ conclusions appeared to reflect the limited and mixed evidence, but lack (...) of reporting of review methods and the limited quality assessment mean the conclusions should be interpreted with caution. Authors' objectives To evaluate the effects of aromatherapy on behavioural and psychological symptoms in dementia (BPSD). Searching MEDLINE, EMBASE, The Cochrane Library and reference lists of relevant papers were searched until March 2007 for English-language reports. Search terms were not reported. Study selection Randomised controlled trials (RCTs) that evaluated the effects

2008 DARE.

522. Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia, and at what cost? A randomised controlled trial

Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia, and at what cost? A randomised controlled trial Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia, and at what cost? A randomised controlled trial Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia, and at what cost (...) ? A randomised controlled trial Charlesworth G, Shepstone L, Wilson E, Thalanany M, Mugford M, Poland F Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Charlesworth G, Shepstone L, Wilson E, Thalanany M, Mugford M, Poland F. Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia

2008 Health Technology Assessment (HTA) Database.

523. Dementia - diagnostic and therapeutic interventions (Vol 2)

Dementia - diagnostic and therapeutic interventions (Vol 2) Dementia - diagnostic and therapeutic interventions (Vol 2) Dementia - diagnostic and therapeutic interventions (Vol 2) Swedish Council on Technology Assessment in Health Care Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Swedish Council on Technology Assessment in Health Care (...) . Dementia - diagnostic and therapeutic interventions (Vol 2) . Stockholm: The Swedish Council on Health Technology Assessment (SBU). Yellow Report No.172E/2. 2008 Authors' objectives This evidence-based review has focused on the most commonly used methods in the diagnostic evaluation of patients who present with cognitive complaints and symptoms. The aims have been to assess the role and validity of the methods in: • Identifying secondary and reversible causes of cognitive impairment • Confirming

2008 Health Technology Assessment (HTA) Database.

524. Dementia - etiology and epidemiology (Vol 1)

Dementia - etiology and epidemiology (Vol 1) Dementia - etiology and epidemiology (Vol 1) Dementia - etiology and epidemiology (Vol 1) Swedish Council on Technology Assessment in Health Care Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Swedish Council on Technology Assessment in Health Care. Dementia - etiology and epidemiology (Vol 1 (...) ) Stockholm: The Swedish Council on Health Technology Assessment (SBU). Yellow Report No.172E/1. 2008 Authors' objectives Purpose The purpose of this SBU project was to use systematic database searches and a review of the scientific literature as a starting point to assess the current state of knowledge about dementia disorders from various perspectives. Those perspectives included occurrence, risk factors for development, diagnostics, care, ethical considerations, ethnicity and drug therapies, as well

2008 Health Technology Assessment (HTA) Database.

525. Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. Full Text available with Trip Pro

Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. To assess the cost effectiveness of community based occupational therapy compared with usual care in older patients with dementia and their care givers from a societal viewpoint.Cost effectiveness study alongside a single blind randomised controlled trial.Memory clinic, day clinic of a geriatrics department, and participants' homes. Patients 135 patients aged > or =65 with mild (...) to moderate dementia living in the community and their primary care givers.10 sessions of occupational therapy over five weeks, including cognitive and behavioural interventions, to train patients in the use of aids to compensate for cognitive decline and care givers in coping behaviours and supervision.Incremental cost effectiveness ratio expressed as the difference in mean total care costs per successful treatment (that is, a combined patient and care giver outcome measure of clinically relevant

2008 BMJ Controlled trial quality: predicted high

526. Ginkgo biloba for prevention of dementia: a randomized controlled trial. Full Text available with Trip Pro

Ginkgo biloba for prevention of dementia: a randomized controlled trial. Ginkgo biloba is widely used for its potential effects on memory and cognition. To date, adequately powered clinical trials testing the effect of G. biloba on dementia incidence are lacking.To determine effectiveness of G. biloba vs placebo in reducing the incidence of all-cause dementia and Alzheimer disease (AD) in elderly individuals with normal cognition and those with mild cognitive impairment (MCI).Randomized, double (...) -blind, placebo-controlled clinical trial conducted in 5 academic medical centers in the United States between 2000 and 2008 with a median follow-up of 6.1 years. Three thousand sixty-nine community volunteers aged 75 years or older with normal cognition (n = 2587) or MCI (n = 482) at study entry were assessed every 6 months for incident dementia.Twice-daily dose of 120-mg extract of G. biloba (n = 1545) or placebo (n = 1524).Incident dementia and AD determined by expert panel consensus.Five hundred

2008 JAMA Controlled trial quality: predicted high

527. Review: sparse evidence supports non-pharmacological interventions for preventing wandering in people with dementia

Review: sparse evidence supports non-pharmacological interventions for preventing wandering in people with dementia Review: sparse evidence supports non-pharmacological interventions for preventing wandering in people with dementia | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: sparse evidence supports non-pharmacological interventions for preventing wandering in people with dementia Article Text Treatment Review: sparse evidence

2008 Evidence-Based Nursing

528. A 93-year-old man with advanced dementia and eating problems. (Abstract)

A 93-year-old man with advanced dementia and eating problems. More than 5 million Americans have dementia, a leading cause of death among persons older than 65 years in the United States. Eating problems typically develop during the advanced stage of dementia, which requires decision making to direct care toward either palliation or more aggressive measures, such as tube feeding. The case of Mr P, a 93-year-old man with end-stage dementia and recent hip fracture, illustrates the issues involved (...) in this challenging crossroads when his daughter is confronted with his failure to orally maintain adequate hydration and nutrition. The discussion reviews the epidemiology and natural history of advanced dementia, the barriers to providing palliative care to patients with this condition, the role of pharmacotherapy, and the treatment options for feeding problems and the advantages and disadvantages of each option, and suggests an approach to help clinicians provide effective and compassionate decision support

2007 JAMA

529. Detecting depression in older adults with dementia.

Detecting depression in older adults with dementia. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures Funding for the National Guideline

2007 University of Iowa Gerontological Nursing Interventions Research Center, Research Translation and Di

530. Dementia.

Dementia. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures Funding for the National Guideline Clearinghouse (NGC) has ended. Learn more about

2007 Singapore Ministry of Health

531. Individualized music for elders with dementia.

Individualized music for elders with dementia. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures Funding for the National Guideline Clearinghouse

2007 University of Iowa Gerontological Nursing Interventions Research Center, Research Translation and Di

532. WITHDRAWN: Reality orientation for dementia. (Abstract)

WITHDRAWN: Reality orientation for dementia. Reality Orientation (RO) was first described as a technique to improve the quality of life of confused elderly people, although its origins lie in an attempt to rehabilitate severely disturbed war veterans, not in geriatric work. It operates through the presentation of orientation information (eg time, place and person-related) which is thought to provide the person with a greater understanding of their surroundings, possibly resulting in an improved (...) sense of control and self-esteem. There has been criticism of RO in clinical practice, with some fear that it has been applied in a mechanical fashion and has been insensitive to the needs of the individual. There is also a suggestion that constant relearning of material can actually contribute to mood and self-esteem problems. There is often little consistent application of psychological therapies in dementia services, so a systematic review of the available evidence is important in order

2007 Cochrane

533. Telephone support met the perceived needs of dementia caregivers for convenient access to information, referral, and emotional support

Telephone support met the perceived needs of dementia caregivers for convenient access to information, referral, and emotional support Telephone support met the perceived needs of dementia caregivers for convenient access to information, referral, and emotional support | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see (...) our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Telephone support met the perceived needs of dementia caregivers for convenient access to information, referral

2007 Evidence-Based Nursing

534. Antipsychotic drug use and mortality in older adults with dementia. (Abstract)

Antipsychotic drug use and mortality in older adults with dementia. Antipsychotic drugs are widely used to manage behavioral and psychological symptoms in dementia despite concerns about their safety.To examine the association between treatment with antipsychotics (both conventional and atypical) and all-cause mortality.Population-based, retrospective cohort study.Ontario, Canada.Older adults with dementia who were followed between 1 April 1997 and 31 March 2003.The risk for death (...) with nonuse among older adults with dementia. The risk for death may be greater with conventional antipsychotics than with atypical antipsychotics.

2007 Annals of Internal Medicine

535. Review: atypical antipsychotic drugs slightly increase mortality rates in elderly people with dementia

Review: atypical antipsychotic drugs slightly increase mortality rates in elderly people with dementia Review: atypical antipsychotic drugs slightly increase mortality rates in elderly people with dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: atypical antipsychotic drugs slightly increase mortality rates in elderly people with dementia Article Text Therapeutics Review: atypical antipsychotic drugs slightly

2007 Evidence-Based Mental Health

536. Yizhi capsule for vascular dementia. (Abstract)

Yizhi capsule for vascular dementia. Vascular dementia (VD) is a syndrome or diagnosis that has different causes and clinical manifestations relating to several different vascular mechanisms and changes in the brain. Some traditional Chinese herbal medicines were developed for treating VD. DH: Yizhi capsule is one such herbal concoction which is reported to improve clinical symptoms significantly. The efficacy and adverse effects of Yizhi capsule need to be reviewed systematically and assessed (...) critically to inform clinical practice and guide the continued search for new treatment regimens.To assess the effectiveness and possible adverse events of 'Yizhi capsule' in treating vascular dementia.The Cochrane Dementia and Cognitive Improvement Group's Specialised Register was searched on 18 September 2006 using the terms yi-zhi, "yi zhi" and yizhi. This database contains trial references from major health care databases and ongoing trial database and is up to date. In addition the review authors

2007 Cochrane

537. The risk of dementia with increased body mass index: a systematic review Full Text available with Trip Pro

The risk of dementia with increased body mass index: a systematic review BACKGROUND: identification of modifiable risk factors is crucial in the prevention of dementia, given its limited treatment options. Studies on increased body mass index (BMI) as a risk factor for dementia show conflicting results. METHODS: we systematically retrieved and reviewed longitudinal population-based studies on increased BMI and dementia using a standard protocol. We searched Medline (1966-2006), Ageline (1978 (...) -2006), PsychInfo (1966-2006), CINAHL (1982-2006), and other relevant databases, including the reference lists of the eligible articles for review. Included studies were subjected to a quality assessment protocol. RESULTS: we identified eight studies that met our selection criteria. These studies covered 1,688 cases of dementia from 28,697 participants. After adjustment for age, smoking, comorbidities, and other confounders, four studies presented significantly increased risk of dementia

2007 EvidenceUpdates

538. Non-pharmacological interventions for wandering of people with dementia in the domestic setting. Full Text available with Trip Pro

Non-pharmacological interventions for wandering of people with dementia in the domestic setting. A number of studies exist of interventions for wandering in the institutional setting, but much less work has been done on wandering in the domestic setting. The prevalence of wandering by people with dementia is difficult to assess; wandering is not a simple or static behaviour and the reasons why people wander remain unclear. In the absence of a theory of wandering and an agreed definition (...) not always do justice to the complex interactions of personal and environmental factors that lead people with dementia to wander. While there seems to be a consensus in the literature that in the majority of cases non-pharmacological approaches may work as well as drug treatment and with fewer side effects, in practice clinicians often resort to drugs as the first line of treatment. This review reports the lack of evidence from RCTs and discusses the range of non-pharmacological interventions that have

2007 Cochrane

539. How Should You Treat Agitation in Patients with Dementia?

How Should You Treat Agitation in Patients with Dementia? How Should You Treat Agitation in Patients with Dementia? – Clinical Correlations Search How Should You Treat Agitation in Patients with Dementia? January 29, 2007 3 min read Case: A 74 year old male with a history of hyperthyroidism, now treated and euthyroid, and with longstanding slowly progressive Alzheimer’s, has now become increasingly agitated at home, pacing the floors and not sleeping. In light of side effects and the recent (...) warning against the use of atypical antipsychotics and the side effects of the older medications, what kind of stepwise approach to medications would you recommend to use to treat his agitation? Commentary By Brian Bronson, MD Clinical Assistant Professor of Psychiatry, Director Consultation and Liaiason Psychiatry, VA New York Harbor Healthcare System Reversible causes of agitation in dementia should be searched for prior to initiating treatment. For example, urinary or respiratory tract infections

2007 Clinical Correlations

540. Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review

Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review Smits C H, de Lange J, Droes R M, Meiland F, Vernooij-Dassen M, Pot A M CRD summary This review concluded that combined (...) intervention programmes aimed at elderly people living at home with dementia and their caregivers may improve some aspects of functioning. Overall, differences between the studies, and methodological limitations of the primary studies and the review, mean that the authors' conclusions may not be reliable. Authors' objectives To determine the effects of combined intervention programmes for both individuals with dementia living at home and their informal caregivers. Searching MEDLINE, PsycINFO, EBM Reviews

2007 DARE.